Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$144M |
| 2 |
Cisco
CSCO
|
+$123M |
| 3 |
Moderna
MRNA
|
+$120M |
| 4 |
JPMorgan Chase
JPM
|
+$95.4M |
| 5 |
FedEx
FDX
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$124M |
| 2 |
Mastercard
MA
|
+$101M |
| 3 |
Home Depot
HD
|
+$95.7M |
| 4 |
Amazon
AMZN
|
+$74.1M |
| 5 |
Eli Lilly
LLY
|
+$72.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.71% |
| 2 | Healthcare | 14.72% |
| 3 | Consumer Discretionary | 14.64% |
| 4 | Industrials | 11.02% |
| 5 | Consumer Staples | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CPRX
951
DELISTED
Catalyst Pharmaceutical
CPRX
| $3.34M | 0.01% |
723,653
-269,778
| -27% | -$1.07M |
|
|
ODP
952
DELISTED
ODP
ODP
| $3.31M | 0.01% |
76,530
-37,728
| -33% | -$1.58M |
|
953
Ultragenyx Pharmaceutical
RARE
$2.54B
| $3.28M | 0.01% |
28,784
-9,234
| -24% | -$1.26M |
|
954
Smith & Wesson
SWBI
$612M
| $3.27M | 0.01% |
187,140
-5,002
| -3% | -$91K |
|
955
Community Trust Bancorp
CTBI
$1.39B
| $3.24M | 0.01% |
73,557
+45,335
| +161% | +$1.86M |
|
|
BIG
956
DELISTED
Big Lots, Inc.
BIG
| $3.21M | 0.01% |
47,007
-5,352
| -10% | -$320K |
|
957
Graco
GGG
$13B
| $3.2M | 0.01% |
44,724
-50,194
| -53% | -$3.56M |
|
958
Radian Group
RDN
$4.86B
| $3.19M | 0.01% |
137,281
-27,276
| -17% | -$581K |
|
959
NovoCure
NVCR
$1.95B
| $3.18M | 0.01% |
24,349
+13,622
| +127% | +$2.15M |
|
960
Roper Technologies
ROP
$41.1B
| $3.18M | 0.01% |
7,894
-9,747
| -55% | -$3.91M |
|
|
CCRN
961
DELISTED
Cross Country Healthcare
CCRN
| $3.16M | 0.01% |
253,285
+88,917
| +54% | +$943K |
|
962
Titan Machinery
TITN
$444M
| $3.16M | 0.01% |
123,803
+14,423
| +13% | +$347K |
|
|
MBT
963
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
| $3.15M | 0.01% |
377,626
+8,976
| +2% | +$78.9K |
|
|
WSR
964
DELISTED
Whitestone REIT
WSR
| $3.14M | 0.01% |
323,819
-4,632
| -1% | -$41.5K |
|
965
Lattice Semiconductor
LSCC
$16.2B
| $3.14M | 0.01% |
69,745
+14,981
| +27% | +$665K |
|
966
Lincoln National
LNC
$8.11B
| $3.14M | 0.01% |
50,402
-29,888
| -37% | -$1.65M |
|
|
WIRE
967
DELISTED
Encore Wire Corp
WIRE
| $3.13M | 0.01% |
46,666
-16,532
| -26% | -$1.07M |
|
968
Axcelis
ACLS
$3.81B
| $3.13M | 0.01% |
76,145
-52,648
| -41% | -$1.96M |
|
969
DexCom
DXCM
$34.4B
| $3.09M | 0.01% |
34,840
-26,136
| -43% | -$2.45M |
|
970
Halozyme
HALO
$12.3B
| $3.08M | 0.01% |
73,833
-1,581
| -2% | -$72.2K |
|
|
BBBY
971
DELISTED
Bed Bath & Beyond Inc
BBBY
| $3.08M | 0.01% |
105,606
-16,211
| -13% | -$454K |
|
972
Ingersoll Rand
IR
$31B
| $3.07M | 0.01% |
62,444
+15,228
| +32% | +$705K |
|
|
TBI
973
Trueblue
TBI
$325M
| $3.06M | 0.01% |
139,187
-1,041
| -0.7% | -$21.3K |
|
|
BKI
974
DELISTED
Black Knight, Inc. Common Stock
BKI
| $3.06M | 0.01% |
41,388
+2,482
| +6% | +$200K |
|
975
Paylocity
PCTY
$8.09B
| $3.05M | 0.01% |
17,469
-2,704
| -13% | -$515K |
|
Similar funds
Cliff Asness's Q1 2021 Portfolio in Review
As of Q1 2021, Cliff Asness held 2,331 positions worth $61.1B, up 8.4% from $56.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Cliff Asness's Q1 2021 filing shows 154 new, 918 increased, 1,058 reduced and 154 closed positions. Its largest new stake was Janus Henderson: 506,382 shares worth $15.8M. The largest sale was Microsoft, an estimated $124M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Cliff Asness's largest Q1 2021 buy was Janus Henderson: 506,382 shares worth $15.8M.
- Cliff Asness added most to Thermo Fisher Scientific in Q1 2021, an estimated $144M increase.
- Cliff Asness's biggest Q1 2021 reduction was Microsoft, cutting an estimated $124M.
- Cliff Asness fully exited State Street SPDR S&P 500 ETF Trust in Q1 2021, selling an estimated $39.7M.
- Cliff Asness's ten largest holdings make up 18% of its $61.1B portfolio in Q1 2021.
- Cliff Asness opened 154 new positions and closed 154 in Q1 2021.
- Cliff Asness's portfolio value rose 8.4% quarter-over-quarter to $61.1B.
Based on AQR Capital Management's 13F filing for Q1 2021, filed 17 May 2021.